“Hematological malignancies are complex, heterogeneous disorders involving multiple recurrent somatic and germline mutations. For acute hematological malignancies, early diagnosis and personalized disease management remain serious challenges. Moreover, there is a growing need for reliable and timely detection of minimal residual disease (MRD) to improve overall clinical management for patients. Genomic biomarkers can provide valuable information to support these needs; however, current biomarker testing algorithms can involve multiple different modalities—often requiring laborious serial processes and time-consuming workflows. These challenges are further exacerbated by the growing number of biomarkers associated with hematological malignancies.
In recent years, next-generation sequencing (NGS) has emerged as a powerful tool for biomarker testing, owing its ability to rapidly and simultaneously interrogate multiple genomic aberrations from a single sample. This FREE webinar for laboratory leaders, with follow-up Q&A, will demonstrate how this technology can now be easily implemented, making it practical for in-house laboratories to quickly generate comprehensive molecular reports for routine clinical care.”